brexucabtagene autoleucel
gilead sciences
['lymphoma', 'tecartus', 'mantle,(-dismantle)', 'car t', 'cart,(-cartitude)', 'lymsm', 'brexu-cel']
brexu-cel (tecartus; kite), a car t-cell therapy, has shown favorable efficacy and safety for the treatment of r/r mantle cell lymphoma in clinical practice, according to results from a real-world experience study. #lymsm #asco22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.